This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Anokion Sa, The University of Chicago. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: Kym Brünggel: Innovator in Immune Tolerance
Introduction
Kym Brünggel is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of immunology, particularly in developing methods to promote immune tolerance. His innovative work has the potential to impact the way protein-based drugs are administered, reducing unwanted immune responses.
Latest Patents
Kym Brünggel holds a patent titled "Compositions and methods concerning immune tolerance." This patent provides compositions that comprise mannose-fused antigens designed to target mannose receptors. The compositions may be utilized to prevent immunity or diminish an immune response to protein-based drugs that would otherwise elicit such responses. He has 1 patent to his name.
Career Highlights
Throughout his career, Kym has worked with prestigious institutions, including the University of Chicago and Anokion SA. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Kym Brünggel has collaborated with notable colleagues such as Jeffrey A. Hubbell and David Scott Wilson. These partnerships have further enhanced his research and innovation in immune tolerance.
Conclusion
Kym Brünggel is a distinguished inventor whose work in immune tolerance is paving the way for advancements in immunology. His contributions are essential for the future of protein-based drug therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile